Andrea Marchetti

12PUBLICATIONS
30CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 19, 2025
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumors.

Sofia Melotti, Francesca Ambrosi, Tania Franceschini

|Sep 11, 2025
Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study.

Costantino Ricci, Francesca Ambrosi, Tania Franceschini

|Oct 16, 2024
Novel Immune Checkpoint Inhibitor Targets in Advanced or Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives.

Samuele Compagno, Chiara Casadio, Linda Galvani

|Nov 22, 2022
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma.

Matteo Rosellini, Andrea Marchetti, Veronica Mollica

|Sep 09, 2022
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study.

Alessandro Rizzo, Veronica Mollica, Andrea Marchetti

|Aug 25, 2022
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis.

Veronica Mollica, Francesco Massari, Elisa Andrini

Pageof 2

Frequent Collaborators

11 joint publications

Francesco Massari

5 joint publications

Matteo Rosellini

4 joint publications

Rodolfo Montironi

3 joint publications

Alessandro Rizzo